Measurement of molecular biomarkers that predict the tumor response in estrogen receptor-positive breast cancers after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy

The aim of this study was to determine the predictive value of the clinical and histopathological characteristics of estrogen receptor (ER)-positive patients treated with dose-dense paclitaxel/carboplatin neoadjuvant chemotherapy (NCT). Pathological complete response (pCR) and the change in tumor si...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Teng, Xu, Fangping, Zhang, Liulu, Zhang, Yifang, Yang, Ciqiu, Cheng, Minyi, Chen, Fulong, Wang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731857/
https://www.ncbi.nlm.nih.gov/pubmed/29254147
http://dx.doi.org/10.18632/oncotarget.19686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731857/
https://www.ncbi.nlm.nih.gov/pubmed/29254147
http://dx.doi.org/10.18632/oncotarget.19686

Ejemplares similares